Ataluren, a new therapeutic for alpha-1 antitrypsin deficient individuals with nonsense mutations

Reeves, E; O’Dwyer, C; Dunlea, D; Wormald, M; Hawkins, P; Alfares, M; Kotton, D; Rowe, S; Wilson, A; McElvaney, N

Journal article

Ataluren, a new therapeutic for alpha-1 antitrypsin deficient individuals with nonsense mutations

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Reeves, E., O’Dwyer, C., Dunlea, D., Wormald, M., Hawkins, P., Alfares, M., Kotton, D., Rowe, S., Wilson, A., & McElvaney, N. (2018). Ataluren, a new therapeutic for alpha-1 antitrypsin deficient individuals with nonsense mutations. American Journal of Respiratory and Critical Care Medicine, 198(8), 1099–1102.

MLA Style

Reeves, E., et al. “Ataluren, a New Therapeutic for Alpha-1 Antitrypsin Deficient Individuals with Nonsense Mutations.” American Journal of Respiratory and Critical Care Medicine, vol. 198, no. 8, American Thoracic Society, 2018, pp. 1099–102.

Chicago Style

Reeves, E, C O’Dwyer, D Dunlea, M Wormald, P Hawkins, M Alfares, D Kotton, S Rowe, A Wilson, and N McElvaney. 2018. “Ataluren, a New Therapeutic for Alpha-1 Antitrypsin Deficient Individuals with Nonsense Mutations.” American Journal of Respiratory and Critical Care Medicine 198 (8): 1099–1102.
Share
Print

Access Document

Files:: Reeves 2018 RESEARCH LETTER Blue- Blue-201802-0338LE.R1.pdf

(Preview, Accepted manuscript, pdf, 404.0KB, Terms of use)

Publisher copy:: 10.1164/rccm.201802-0338LE

Authors

+ Reeves, E More by this author

Role:: Author

+ O’Dwyer, C More by this author

Role:: Author

+ Dunlea, D More by this author

Role:: Author

+ Wormald, M More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Biochemistry
Oxford college:: Oriel College
Role:: Author

+ Hawkins, P More by this author

Role:: Author

More authors...

Publisher:: American Thoracic Society
Journal:: American Journal of Respiratory and Critical Care Medicine More from this journal
Volume:: 198
Issue:: 8
Pages:: 1099–1102
Publication date:: 2018-07-16
Acceptance date:: 2018-05-19
DOI:: 10.1164/rccm.201802-0338LE
EISSN:: 1535-4970
ISSN:: 1073-449X

Keywords:: patient-derived iPSC hepatic cells

ataluren

alpha-1 antitrypsin

premature termination codons
Pubs id:: pubs:853585
UUID:: uuid:671ad577-d856-456b-8954-c7214a97d4b0
Local pid:: pubs:853585
Source identifiers:: 853585
Deposit date:: 2018-05-23

Terms of use

Copyright holder:: American Thoracic Society
Notes:: Copyright © 2018 by the American Thoracic Society. This is the accepted manuscript version of the article. The final version is available online from the American Thoracic Society at: https://doi.org/10.1164/rccm.201802-0338LE

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

Journal article

Ataluren, a new therapeutic for alpha-1 antitrypsin deficient individuals with nonsense mutations

Actions

Access Document

Authors

Terms of use

Views and Downloads

Altmetrics

Dimensions

Journal article

Ataluren, a new therapeutic for alpha-1 antitrypsin deficient individuals with nonsense mutations

Actions

Access Document

Authors

Bibliographic Details

Item Description

Terms of use

Metrics

Views and Downloads

Altmetrics

Dimensions